Colorectal cancer natural history: Difference between revisions
Jump to navigation
Jump to search
YazanDaaboul (talk | contribs) |
No edit summary |
||
| Line 6: | Line 6: | ||
==Overview== | ==Overview== | ||
The progression from an edematous polyp to colorectal cancer may take 10-15 years. Complications may arise if the cancer is not eradicated or from the treatment itself. Complications include [[intestinal obstruction]], gastrointestinal bleeding, [[metastasis]], cancer recurrence, [[radiation therapy]] | The progression from an edematous polyp to colorectal cancer may take 10-15 years. Complications may arise if the cancer is not eradicated or from the treatment itself. Complications include [[intestinal obstruction]], gastrointestinal bleeding, [[metastasis]], cancer recurrence, [[radiation therapy]] adverse effects, [[chemotherapy]] adverse effects, post-surgical complications, metachronous colon cancer, and death. The 5 year survival rates depend upon the stage of colorectal cancer. | ||
==Natural history== | ==Natural history== | ||
| Line 12: | Line 12: | ||
*The progression from an [[adenomatous]] polyp to colorectal cancer may take 10-15 years<ref name="pmid10089106">{{cite journal| author=Winawer SJ| title=Natural history of colorectal cancer. | journal=Am J Med | year= 1999 | volume= 106 | issue= 1A | pages= 3S-6S; discussion 50S-51S | pmid=10089106 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10089106 }} </ref> | *The progression from an [[adenomatous]] polyp to colorectal cancer may take 10-15 years<ref name="pmid10089106">{{cite journal| author=Winawer SJ| title=Natural history of colorectal cancer. | journal=Am J Med | year= 1999 | volume= 106 | issue= 1A | pages= 3S-6S; discussion 50S-51S | pmid=10089106 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10089106 }} </ref> | ||
*It is a multistep process that involves genetics, abnormalities of cell regulation, and environmental triggers | |||
*The patient may present with | |||
:*Change in bowel habits such as change in frequency, change in the quality of stools, change in consistency of stools | |||
:*Hematochezia or bleeding per rectum | |||
:*Mucus in stools | |||
:*Abdominal cramps or discomfort | |||
:*Tenesmus | |||
:*Diminished caliber of stools | |||
:*Rectal pain (usually associated with rectal cancer) | |||
:*Nausea/vomiting | |||
:*Unexplained weight loss | |||
:*Unexplained loss of appetite | |||
:*Weakness | |||
:*Fatigue | |||
:*Dizziness | |||
:*Palpitations | |||
*If the cancer spreads to other organs, the following symptoms may develop: | |||
:*Lungs - dyspnea, cough with blood-stained sputum, persistent pain or discomfort in the chest | |||
:*Liver - abdominal pain, swelling in hands/feet, itchiness, jaundice, dark-colored urine | |||
:*Bones - pain, fractures | |||
:*Brain/spinal cord - pain, confusion, memory loss, headache, blurred or double vision, difficulty with speech, difficulty with movement or seizures | |||
==Complications== | ==Complications== | ||
Complications of colorectal cancer include<ref name="Tebbutt2003">{{cite journal|last1=Tebbutt|first1=N C|title=Intestinal complications after chemotherapy for patients with unresected primary colorectal cancer and synchronous metastases|journal=Gut|volume=52|issue=4|year=2003|pages=568–573|issn=00175749|doi=10.1136/gut.52.4.568}}</ref>: | Complications of colorectal cancer include<ref name="Tebbutt2003">{{cite journal|last1=Tebbutt|first1=N C|title=Intestinal complications after chemotherapy for patients with unresected primary colorectal cancer and synchronous metastases|journal=Gut|volume=52|issue=4|year=2003|pages=568–573|issn=00175749|doi=10.1136/gut.52.4.568}}</ref>: | ||
| Line 37: | Line 42: | ||
*[[Metastasis]] - usually is seen in the liver and lungs but may occur in other sites | *[[Metastasis]] - usually is seen in the liver and lungs but may occur in other sites | ||
*Cancer recurrence - local (site of the original tumor), regional (in the lymph nodes near the primary tumor) or distal (in another part of the body) | *Cancer recurrence - local (site of the original tumor), regional (in the lymph nodes near the primary tumor) or distal (in another part of the body) | ||
*[[ | *Common [[radiation therapy]] adverse effects - skin discoloration, skin burns, [[headache]], [[fatigue]], [[hair loss]], [[nausea]], [[vomiting]], and/or [[confusion]] | ||
*[[ | *Common [[chemotherapy]] adverse effects - [[hair loss]], [[fatigue]], [[weakness]], [[nausea]], [[vomiting]], risk of [[infection]], and/or [[diarrhea]] | ||
* | *Common post-surgical complications - colon leakage, organ damage, hematoma, bleeding, infection | ||
*Metachronous colon cancer (development of a second primary cancer) - develops six or more months after the primary tumor and is often in another site | *Metachronous colon cancer (development of a second primary cancer) - develops six or more months after the primary tumor and is often in another site | ||
*Death | *Death | ||
==Prognosis== | ==Prognosis== | ||
Survival is directly related to the detection and the type of cancer involved. Survival rates for early stage detection is about 5 times that of late stage cancers. | Survival is directly related to the detection and the type of cancer involved. Survival rates for early stage detection is about 5 times that of late stage cancers. | ||
The 5 year survival rates depending upon the stage of colorectal cancer are as follows: | The 5 year survival rates depending upon the stage of colorectal cancer are as follows: | ||
| Line 125: | Line 124: | ||
|} | |} | ||
CEA level may also be directly related to the prognosis of disease, since its concentration correlates with the bulk of tumor tissue. | |||
'''Poor prognostic factors of patients with liver metastasis include the following:''' | '''Poor prognostic factors of patients with liver metastasis include the following:''' | ||
*[[Synchronous]] (diagnosed simultaneously) liver and primary colorectal tumors | *[[Synchronous]] (diagnosed simultaneously) liver and primary colorectal tumors | ||
*A short time between detecting the primary cancer and subsequent development of liver metastasis | *A short time between detecting the primary cancer and subsequent development of liver metastasis | ||
*Multiple metastatic lesions | *Multiple metastatic lesions | ||
* | *Large-sized metastatic lesions, which can be measured by a high concentration of carcino-embryonic antigen (CEA) | ||
==References== | ==References== | ||
Revision as of 18:39, 16 July 2015
|
Colorectal cancer Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Colorectal cancer natural history On the Web |
|
American Roentgen Ray Society Images of Colorectal cancer natural history |
|
Risk calculators and risk factors for Colorectal cancer natural history |
To view the natural history of familial adenomatous polyposis (FAP), click here
To view the natural history of hereditary nonpolyposis colorectal cancer (HNPCC), click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Saarah T. Alkhairy, M.D.; Elliot B. Tapper, M.D.
Overview
The progression from an edematous polyp to colorectal cancer may take 10-15 years. Complications may arise if the cancer is not eradicated or from the treatment itself. Complications include intestinal obstruction, gastrointestinal bleeding, metastasis, cancer recurrence, radiation therapy adverse effects, chemotherapy adverse effects, post-surgical complications, metachronous colon cancer, and death. The 5 year survival rates depend upon the stage of colorectal cancer.
Natural history
- The progression from an adenomatous polyp to colorectal cancer may take 10-15 years[1]
- It is a multistep process that involves genetics, abnormalities of cell regulation, and environmental triggers
- The patient may present with
- Change in bowel habits such as change in frequency, change in the quality of stools, change in consistency of stools
- Hematochezia or bleeding per rectum
- Mucus in stools
- Abdominal cramps or discomfort
- Tenesmus
- Diminished caliber of stools
- Rectal pain (usually associated with rectal cancer)
- Nausea/vomiting
- Unexplained weight loss
- Unexplained loss of appetite
- Weakness
- Fatigue
- Dizziness
- Palpitations
- If the cancer spreads to other organs, the following symptoms may develop:
- Lungs - dyspnea, cough with blood-stained sputum, persistent pain or discomfort in the chest
- Liver - abdominal pain, swelling in hands/feet, itchiness, jaundice, dark-colored urine
- Bones - pain, fractures
- Brain/spinal cord - pain, confusion, memory loss, headache, blurred or double vision, difficulty with speech, difficulty with movement or seizures
Complications
Complications of colorectal cancer include[2]:
- Intestinal obstruction
- Intestinal perforation
- Fistula formation
- Gastrointestinal bleeding
- Metastasis - usually is seen in the liver and lungs but may occur in other sites
- Cancer recurrence - local (site of the original tumor), regional (in the lymph nodes near the primary tumor) or distal (in another part of the body)
- Common radiation therapy adverse effects - skin discoloration, skin burns, headache, fatigue, hair loss, nausea, vomiting, and/or confusion
- Common chemotherapy adverse effects - hair loss, fatigue, weakness, nausea, vomiting, risk of infection, and/or diarrhea
- Common post-surgical complications - colon leakage, organ damage, hematoma, bleeding, infection
- Metachronous colon cancer (development of a second primary cancer) - develops six or more months after the primary tumor and is often in another site
- Death
Prognosis
Survival is directly related to the detection and the type of cancer involved. Survival rates for early stage detection is about 5 times that of late stage cancers.
The 5 year survival rates depending upon the stage of colorectal cancer are as follows:
The numbers below come from the National Cancer Institute's SEER database, looking at people diagnosed with colon cancer between 2004 and 2010.
| Stage | 5-year Relative Survival Rate |
| I | 92% |
| IIA | 87% |
| IIB | 63% |
| IIIA | 89% |
| IIIB | 69% |
| IIIC | 53% |
| IV | 11% |
The numbers below come from the National Cancer Institute's SEER database, looking at people diagnosed with rectal cancer between 2004 and 2010.
| Stage | 5-year Relative Survival Rate |
| I | 87% |
| IIA | 80% |
| IIB | 49% |
| IIIA | 84% |
| IIIB | 71% |
| IIIC | 58% |
| IV | 12% |
CEA level may also be directly related to the prognosis of disease, since its concentration correlates with the bulk of tumor tissue.
Poor prognostic factors of patients with liver metastasis include the following:
- Synchronous (diagnosed simultaneously) liver and primary colorectal tumors
- A short time between detecting the primary cancer and subsequent development of liver metastasis
- Multiple metastatic lesions
- Large-sized metastatic lesions, which can be measured by a high concentration of carcino-embryonic antigen (CEA)
References
- ↑ 1.0 1.1 Winawer SJ (1999). "Natural history of colorectal cancer". Am J Med. 106 (1A): 3S–6S, discussion 50S-51S. PMID 10089106.
- ↑ Tebbutt, N C (2003). "Intestinal complications after chemotherapy for patients with unresected primary colorectal cancer and synchronous metastases". Gut. 52 (4): 568–573. doi:10.1136/gut.52.4.568. ISSN 0017-5749.